TCL Archive Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer March 26, 2010
TCL Archive FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion January 3, 1992
TCL Archive House report offers encouragement, but little else, for NCI’s 2015 plan, endorses “biobank” and caBIG. July 1, 2005
